Column A identifies the study group (PHI patients: MAIN, CHI patients: VEMAN, HC: healthy controls). Column B identifies the code of each patient who participates to the studies. Column C identifies t
Data from Review of Symptoms Form [CRF 7] Study Description ATN 026 investigated the association between HLA class I genotypes and differing HIV-1 disease progression. The study assessed HIV-1 specifi
To assess the prognostic value of baseline HIV-1 DNA levels, a meta-analysis was conducted according to the PROSPERO protocol (CRD42024619050) based on data from studies published until March 4, 2025.
Cox proportional hazard analysis from 6 years after seroconversion to AIDS or CD4 cell counts below 200 cells per µl blood.1number of individuals included in the analysis.2number of individuals that r